HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diarrhea in the intensive care unit: the role of hypoalbuminemia and the response to a chemically defined diet (case reports and review of the literature).

Abstract
We describe five patients who developed acute kwashiorkor-like hypoalbuminemia during their hospitalization in the intensive care unit. With the initiation of enteral alimentation, diarrhea ensued and continued for at least 48 hours. Routine evaluation for the cause of diarrhea including stool culture for enteric pathogens, white blood cells, ova and parasites, Clostridium difficile cytotoxin, and flexible sigmoidoscopy was negative. When a peptide based formula (Vital HN, Ross Laboratories, Columbus, OH) was initiated, there was a significant reduction in stool output within 24 hours. In three of the five cases, hypoalbuminemia corrected within 2 weeks. Four of the five patients were discharged from the hospital. Although several reports have acknowledged the association between hypoalbuminemia and impaired gastrointestinal absorption, no previous enteral formula has been tolerated in these acutely ill patients until serum albumin levels had improved. Further studies will be required to confirm the better gastrointestinal tolerance of this peptide based formula in patients with severe hypoalbuminemia.
AuthorsR R Brinson, W D Curtis, M Singh
JournalJournal of the American College of Nutrition (J Am Coll Nutr) Vol. 6 Issue 6 Pg. 517-23 (Dec 1987) ISSN: 0731-5724 [Print] United States
PMID3121713 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Peptides
  • Serum Albumin
Topics
  • Adult
  • Critical Care
  • Diarrhea (blood, etiology, therapy)
  • Enteral Nutrition (adverse effects)
  • Female
  • Food, Formulated
  • Humans
  • Male
  • Middle Aged
  • Peptides (administration & dosage)
  • Postoperative Care
  • Serum Albumin (deficiency)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: